CurrentEndo
Get Weekly

Topic · page 26 of 64

Obesity

Overweight and obesity in adults and children: weight-lowering drugs, lifestyle, metabolic and bariatric surgery against other treatment, weight-related disease, lipodystrophy

Briefs 1,001–1,040 of 2,541 placed here, newest publication first

Briefs in Obesity

Newest publication first

  1. Nat Med

    Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial

    Randomized controlled trial

  2. Ann Intern Med

    Improvements in Cardiometabolic Risk Factors by Weight Reduction: A Post Hoc Analysis of Adults With Obesity Randomly Assigned to Tirzepatide

    Secondary analysis

  3. J Clin Endocrinol Metab

    Multiomics of Human Obesity and Related Multisystem Diseases

    Mechanistic study

  4. N Engl J Med

    Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial

    Randomized controlled trial

  5. Nat Med

    An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial

    Randomized controlled trial

  6. N Engl J Med

    Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity

    Randomized controlled trial

  7. Obesity (Silver Spring)

    Fat taste sensitivity in women with obesity: transcriptomic analysis of fungiform papillae before and after bariatric surgery

    Cohort study

  8. Obesity (Silver Spring)

    Tirzepatide for reduction of morbidity and mortality in adults with obesity: rationale and design of the SURMOUNT ‐ MMO trial

    Trial design

  9. Lancet Diabetes Endocrinol

    Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Randomized controlled trial

  10. Lancet

    Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study

    Randomized controlled trial

  11. Lancet

    Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial

    Randomized controlled trial

  12. Diabetes Obes Metab

    Efficacy and safety of danuglipron ( PF ‐06882961) in adults with obesity: A randomized, placebo‐controlled, dose‐ranging phase 2b study

    Randomized controlled trial

  13. Diabetes Obes Metab

    Mediterranean diet vs. the Australian guide to healthy eating ( AGHE ) on body composition and glucose metabolism: A randomized controlled trial

    Randomized controlled trial

  14. Pediatr Obes

    The impact of community‐based childhood obesity prevention interventions in Australia by socio‐economic position: An individual participant data meta‐analysis

    Meta-analysis

  15. Diabetes Obes Metab

    Interaction between dietary omega‐3 polyunsaturated fatty acids, obesity and gut microbiota in preclinical models: A systematic review of randomized controlled trials

    Meta-analysis

  16. Diabetes Obes Metab

    Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes

    Randomized controlled trial

  17. Diabetes Obes Metab

    Socio‐demographic and clinical factors associated with the receipt of anti‐obesity medication prescriptions and metabolic and bariatric surgery among eligible all of Us participants

    Cross-sectional study

  18. Obesity (Silver Spring)

    Associations of dietary patterns and obesity development in school‐aged children: results from the CHILD Cohort Study

    Cohort study

  19. Pediatr Obes

    Leukocyte telomere length and birth characteristics associated with obesity in infancy in a predominantly Latinx cohort

    Cohort study

  20. Pediatr Obes

    Ultra‐processed food intake and risk of obesity among schoolchildren aged 8–12 years living in Victoria, Australia

    Cross-sectional study

  21. Int J Obes (Lond)

    Do lower antenatal blood pressure cut-offs in pregnant women with obesity identify those at greater risk of adverse maternal and perinatal outcomes? A secondary analysis of data from the UK Pregnancies Better Eating and Activity Trial (UPBEAT)

    Secondary analysis

  22. Int J Obes (Lond)

    Detecting monogenic obesity: a systematic exome-wide workup of over 500 individuals

    Cohort study

  23. Obesity (Silver Spring)

    Effects of obesity‐associated plasma markers on adipose stem cell function and epigenetic regulation

    Mechanistic study

  24. Diabetes Obes Metab

    Hormonal adaptations to weight loss: Responses to an oral glucose load 4 weeks after obesity surgery and low‐energy diet

    Secondary analysis

  25. Obesity (Silver Spring)

    Variations in weight loss and glycemic outcomes after sleeve gastrectomy by race and ethnicity

    Cohort study

  26. Obesity (Silver Spring)

    Beyond weight loss: exploring bile acid modulations after bariatric surgery and their impact on type 2 diabetes across 5 years

    Cohort study

  27. Int J Obes (Lond)

    Predictors of BMI reduction with phentermine/topiramate in adolescents with obesity

    Secondary analysis

  28. Obesity (Silver Spring)

    Modeling potential cost‐effectiveness of tirzepatide versus lifestyle modification for patients with overweight and obesity

    Research article

  29. Pediatr Obes

    Preferences and willingness to pay for early childhood healthy lifestyle initiative outcomes: A discrete choice experiment

    Research article

  30. Diabetes Care

    Health Expenditures Decline After Bariatric Surgery for Patients With Type 2 Diabetes

    Cohort study

  31. Pediatr Obes

    Racial and ethnic disparities in obesity trends among US children and adolescents aged 2–19, 2011–2023

    Cross-sectional study

  32. J Clin Endocrinol Metab

    Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases

    Cohort study

  33. Diabetes Obes Metab

    Incretin‐based therapies for individuals with obesity and heart failure with mildly reduced or preserved ejection fraction: A systematic review and meta‐analysis of randomized controlled trials

    Meta-analysis

  34. Int J Obes (Lond)

    Randomized controlled trial of time-restricted eating: secondary analyses of breath acetone

    Secondary analysis

  35. Pediatr Obes

    Does food reward predict changes in weight and body composition during multidisciplinary interventions in adolescents with obesity? Bayesian and frequentist meta‐analyses

    Meta-analysis

  36. Obesity (Silver Spring)

    Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status

    Cohort study

  37. Diabetes Obes Metab

    Efficacy and safety of once‐weekly tirzepatide in Japanese participants with type 2 diabetes who have obesity or overweight: Subpopulation analysis of the SURMOUNT ‐2 trial

    Secondary analysis

  38. Int J Obes (Lond)

    A systematic review of influences on engagement with remote health interventions targeting weight management for individuals living with excess weight

    Meta-analysis

  39. Obesity (Silver Spring)

    Metabolic clearance rate of insulin across the glucose tolerance spectrum by race and ethnicity in youth with obesity

    Cross-sectional study

  40. Int J Obes (Lond)

    Association between plasma proteomic dynamic changes and metabolic outcomes in patients undergoing bariatric surgery

    Cohort study

All 2,541 Briefs in ExploreShowing Briefs 1,001–1,040 of 2,541, newest first